Innerwell

🗓 Founded 2021👥 38 employees💰 Last funded Jan 2025
Mental Health Care🌐 helloinnerwell.com
Website LinkedIn
Meet Innerwell, a revolutionary psychedelic therapy platform with an emphasis on therapy. We believe that when deeply personal therapeutic relationships meet the giant leaps we’ve made in psychedelic medicine, unthinkable transformations are possible. What separates our patient experience? 👩‍⚕️ Licensed clinicians with specialized training in psychedelic-assisted therapy, starting with Ketamine 📱 Personalized digital care to support patients before, during, and after their experience 📊 Measurement and data focused approach to improving patient outcomes We’re bringing a true ketamine-assisted psychotherapy experience virtual - and that’s just the beginning, as we’re already working towards expanding the gold standard model of psychedelic therapy for at-home and in-person treatment aided by groundbreaking medicine like psilocybin and MDMA.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Innerwell?
Innerwell has 1 investors on record on gritt.io, 1 mid-stage.
When did Innerwell last raise funding?
The most recent investment in Innerwell recorded on gritt.io was in January 2025.
When was Innerwell founded?
Innerwell was founded in 2021.
What industry is Innerwell in?
Innerwell operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.